Home › Cholesterol › North Carolina
Cholesterol clinical trials in North Carolina
7 studies for Cholesterol are looking for participants at sites in North Carolina.
Cities in North Carolina
Pharmacogenomic Informed Statin Prescribing
- Durham VA Medical Center, Durham, NC, Durham
Recruiting
Ages 40 to 75 · All sexes · Updated Nov 2, 2026 · NCT06568601Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Asheville Cardiology Associates Research Department, Asheville
- Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
- Mecklenburg Heart Specialists, Charlotte
- and 6 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
- Research Site, Rocky Mount
- Research Site, Statesville
- Research Site, Wilmington
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT07619118A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Duke Early Phase Clinical Research, Durham
- Peters Medical Research, High Point
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Durham
- Research Site, Morehead City
- Research Site, Statesville
- and 2 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Monroe Biomedical Research, Monroe
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Wake Forest University Health Sciences, Winston-Salem
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Feb 27, 2026 · NCT06488105From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.